Zero, a global leader in multi-asset enterprise trading technology solutions, is kicking off 2025 with the announcement of a new brand campaign "Driving Innovation", complemented by the sponsorship of ...

CIRCA Scientific is pleased to announce the launch of its innovative CrossWisetm RF Transseptal Access System, designed to provide precise puncture of the septal wall with a streamlined, zero-exchange ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries, announced that it has joined the ...

WuXi AppTec said Tuesday it has entered into a definitive agreement to sell its WuXi Advanced Therapies operations at the Philadelphia Navy Yard to New York health care investment firm Altaris.

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Wuxi Biologics ...

JPMorgan upgraded Wuxi Biologics (WXXWY) to Overweight from Neutral with a price target of HK$20, up from HK$13, citing expected order growth and improved margins. Although the newsthat WuXi Bio ...

In addition, WuXi AppTec participates in global efforts to advance sustainability. In 2024, WuXi AppTec joined the United Nations Global Compact (UNGC) to support its ten sustainability principles. In ...

Dec 24 (Reuters) - China's WuXi AppTec (603259.SS), opens new tab said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and ...

Bengaluru: China's WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit ...